Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00574990 · ClinicalTrials.gov registry record

Minimizing Harm From ADEs by Improving Nurse-Physician Communication

A clinical trial, sponsored by US Department of Veterans Affairs.

Completed
Registry status
39
Enrollment target

NCT00574990: Completed study, sponsored by US Department of Veterans Affairs.

NCT00574990 is a clinical trial that has completed, run by US Department of Veterans Affairs. The registered enrollment target is 39 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00574990 has completed, sponsored by US Department of Veterans Affairs.

COMPLETED
Registry status
39 participants
Enrollment target

Study Summary

The purpose of this research study is to examine the clinical processes of care involved with the sharing and communicating of medication management information in the inpatient setting between nurses, pharmacists and physicians. The study is unique in that few studies have examined communication content and processes in depth and in relation to specific clinical care. The study will be conducted in two phases. The first phase involves using three focus groups across three sites (a total of nine) each involving between 6-8 individuals to examine perceptions regarding role and procedures associated with medication management. The focus group discussions will be tape-recorded and analyzed using qualitative methods. The information gleaned will assist us in identifying patterns of problems in enhancing the sharing of information, to develop better measures for assessing communication as well as designing effective interventions to enhance communication. In the second phase of the study, 400 2-4 hour time slots will be randomly selected over about a 5-week period for nursing staff and 500 events over a 6-week period for physicians to conduct ethnographic observations during which specific communication events will be recorded and coded. Every effort will be made to minimize interruptions during clinical care. This research has not been done in terms of medication management content in the inpatient setting (non-ICU).

Primary Outcome

Observation periods were approximately two-hours long. Some providers were observed more than once. The number of communication events were counted per each observation period.

Trial Details

FieldValue
Enrollment Target 39 participants
Start Date 2008-01
Est. Completion 2009-09
US Department of Veterans Affairs

632 total trials

What the finished NCT00574990 record still lists

NCT00574990 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 39 participants, a relatively small participant target.

The record links to 0 conditions, and to 0 interventions.

NCT00574990 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00574990 about?

NCT00574990 is a clinical study titled "Minimizing Harm From ADEs by Improving Nurse-Physician Communication". The purpose of this research study is to examine the clinical processes of care involved with the sharing and communicating of medication management information in the inpatient setting between nurses, pharmacists and physicians. The study is unique in that few studies have examined communication co...

What is the current status of trial NCT00574990?

This trial is currently completed. The enrollment target is 39 participants. The study started on 2008-01. Estimated completion is 2009-09.

Who is sponsoring clinical trial NCT00574990?

This trial is sponsored by US Department of Veterans Affairs, which has 632 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03465592 · 39 participants · Phase 1

    Trial of Nivolumab Following Partially Human Leukocyte Antigen (HLA) Mismatched BMT in Children & Adults With Sarcoma

  • NCT03961776 · 39 participants

    Monitoring Treatment Response With On-board DWI During Neo-adjuvant Chemo-radiation for Rectal Cancer Using Magnetic Resonance-guided-radiotherapy Systems

  • NCT04050280 · 39 participants · Phase 2

    CLAG-GO for Patients With Persistent, Relapsed or Refractory AML

  • NCT04190862 · 39 participants · Phase 1

    E-CEL UVEC as an Adjunct Cell Therapy for Treatment of Anal Fistulas

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00574990, the US trial registry maintained by the National Library of Medicine. NCT00574990 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.